BJA FY25 Harold Rogers Prescription Drug Monitoring Program Training and Technical Assistance Program
ID: 358244Type: Posted
Overview

Buyer

Bureau of Justice Assistance (USDOJ-OJP-BJA)

Award Range

$0 - $6M

Eligible Applicants

Small Businesses

Funding Category

Law, Justice and Legal Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358244

Additional Information

https://bja.ojp.gov/funding/opportunities/o-bja-2025-172339
Timeline
    Description

    The Bureau of Justice Assistance is offering a funding opportunity titled "BJA FY25 Harold Rogers Prescription Drug Monitoring Program Training and Technical Assistance Program." This program aims to provide training and technical assistance to grantees and practitioners to enhance the use of state Prescription Drug Monitoring Programs (PDMPs) in order to combat the diversion and misuse of controlled substances, particularly opioids and other prescription drugs. The initiative is crucial for improving public health and safety by ensuring effective monitoring and management of prescription drug use. Interested applicants, specifically small businesses, can apply for a cooperative agreement with an award ceiling of $6 million, and the application deadline is March 18, 2025. For further inquiries, applicants can reach out via email at grants@ncjrs.gov or visit the additional information link at https://bja.ojp.gov/funding/opportunities/o-bja-2025-172339.

    Point(s) of Contact
    grants@ncjrs.gov
    Files
    No associated files provided.
    Similar Opportunities
    Fiscal Year 2025 Behavioral Health National Training and Technical Assistance Partner (NTTAP) Cooperative Agreement
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a cooperative agreement for the Fiscal Year 2025 to establish a Behavioral Health National Training and Technical Assistance Partner (NTTAP). This initiative aims to provide comprehensive training and technical assistance focused on enhancing behavioral health services in health centers, addressing public health issues, and improving operational effectiveness while reducing health disparities. The program is critical for ensuring that health centers can deliver evidence-informed behavioral health services effectively. The estimated total funding for this opportunity is $2,000,000, with approximately 20 awards expected. Interested applicants can reach out to Marlene Saez-Banks at msaezbanks@hrsa.gov or by phone at 301-443-8806. Key deadlines include the synopsis posting on March 21, 2025, and the closing date for applications on May 20, 2025, with projects expected to start on September 1, 2025.
    Rural Communities Opioid Response Program-Stimulant Support
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Rural Communities Opioid Response Program-Stimulant Support," aimed at enhancing access to prevention, treatment, and recovery services for stimulant use disorder in rural areas. This program seeks to reduce the prevalence and impact of stimulant use disorder, with a focus on coordinated and comprehensive service delivery. The estimated total program funding is $20 million, with an award ceiling of $500,000 and approximately 10 awards expected. Interested applicants, particularly small businesses, can reach out to Sarah O'Donnell at 301-443-0298 or via email at ruralopioidresponse@hrsa.gov for further information. Key deadlines include an estimated synopsis post date of December 16, 2024, and a close date of March 19, 2025, with project start anticipated on September 1, 2025.
    FY2025 APS- Opioid and Substance Use Disorder Intervention
    Administration for Community Living
    The Administration for Community Living (ACL) is offering a funding opportunity titled "FY2025 APS- Opioid and Substance Use Disorder Intervention" through a cooperative agreement aimed at enhancing services for clients affected by the opioid epidemic. The initiative seeks to award up to five cooperative agreements to implement evidence-informed interventions that will increase the availability of in-home and community-based social, health, and mental/behavioral health services for Adult Protective Services (APS) clients and their families. This funding is crucial for equipping APS professionals with the necessary tools and training to improve the health and well-being of individuals experiencing abuse, neglect, and exploitation, particularly those impacted by substance use disorders. Interested applicants can apply for funding amounts ranging from $200,000 to $500,000, with a total program funding of $2 million available. The application period is open until August 12, 2025, with awards expected to be announced by September 15, 2025. For further inquiries, applicants may contact Kari Benson at 202-401-4634 or via email at contactelderjustice@acl.hhs.gov.
    Provider’s Clinical Support System – Medication Assisted Treatment Grant
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Provider’s Clinical Support System – Medication Assisted Treatment Grant" aimed at expanding training for primary care providers in the prevention and treatment of opioid use disorders (OUD) and chronic pain management. This grant seeks to enhance understanding and access to medication-assisted treatment (MAT) through the training of providers authorized to prescribe FDA-approved schedule III medications for addictive disorders, specifically targeting national professional medical organizations such as ASAM, AAAP, AMA, AOAAM, and APA. With an estimated total program funding of $2,000,000 and the expectation of one award, interested applicants can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further details. The synopsis for this opportunity is expected to be posted on February 15, 2022.
    National Coordinating Center for Accelerating Primary Care Association Technical Assistance and Training Impact Cooperative Agreement
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a cooperative agreement titled "National Coordinating Center for Accelerating Primary Care Association Technical Assistance and Training Impact." This initiative aims to enhance the capacity of Primary Care Associations (PCAs) to improve the operational and clinical efficiency of health centers through collaboration, engagement, and the sharing of best practices. The program is crucial for strengthening health service delivery, particularly in underserved communities, by fostering effective training and technical assistance. The estimated total funding for this opportunity is $1,000,000, with approximately 20 awards expected. Interested applicants, including public entities, institutions of higher education, tribes, for-profit organizations, small businesses, and nonprofits, should contact Marlene Saez-Banks at msaezbanks@hrsa.gov for further information. The application period is anticipated to open on April 30, 2025, with a closing date of June 30, 2025, and project start dates expected around September 1, 2025.
    Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering a federal grant titled "Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities." This grant aims to enhance understanding of drug shortages, particularly those susceptible to health fraud, and to identify outsourcing facilities that can help meet these critical needs, thereby strengthening the drug supply chain. The funding, totaling $3 million with an award ceiling of $3 million and an expected two awards, will support research and development initiatives aimed at mitigating persistent drug shortages and stabilizing the supply of essential medications. Interested applicants can reach out to Patrick Johnson at patrick.johnson@fda.hhs.gov for further information, with the grant opportunity posted for the fiscal year 2025.
    Rural Communities Opioid Response Program (RCORP)-Planning
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering the Rural Communities Opioid Response Program (RCORP)-Planning grant to support organizations in rural areas in developing comprehensive systems for addressing substance use disorders (SUD), particularly focusing on opioid misuse. This grant aims to assist rural communities in building partnerships and foundational capacity to implement sustainable prevention, treatment, and recovery services, addressing the broader mental and behavioral health needs of individuals affected by substance use. With an estimated total program funding of $4 million and an award ceiling of $100,000 for approximately 40 awards, eligible applicants include domestic public or private entities, both non-profit and for-profit. Interested parties can reach out to Lynlee Tanner Stapleton at 301-443-5764 or via email at ruralopioidresponse@hrsa.gov for further information, with applications due by April 6, 2026, and awards expected to be announced by August 1, 2026.
    HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to release a Notice of Funding Opportunity (NOFO) titled "HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)" aimed at supporting research that translates addiction-related findings into practical applications to combat the opioid crisis and overdose events. This initiative seeks to identify and address factors influencing substance use and overdose deaths, focusing on developing effective, scalable interventions that integrate evidence-based practices into routine healthcare. Interested small businesses are encouraged to prepare for this opportunity, with applications expected to be solicited after the estimated synopsis post date of August 1, 2025, and closing on October 16, 2025. For further inquiries, potential applicants can contact Dr. Tisha Wiley at tisha.wiley@nih.gov or by phone at 301-594-4381.
    Behavioral Health Partnership for Early Diversion of Adults and Youth
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Behavioral Health Partnership for Early Diversion of Adults and Youth." This program aims to establish or expand initiatives that divert individuals with mental illness or co-occurring disorders from the criminal or juvenile justice systems to community-based mental health and substance use disorder services prior to arrest and booking. Such programs are crucial for enhancing public health and safety by providing necessary support to vulnerable populations. The estimated total program funding is $2 million, with approximately six awards expected, and interested applicants can reach out to Roxanne Castenada at roxanne.castenada@samhsa.hhs.gov or (240) 276-1917 for further information. The synopsis is anticipated to be posted on December 16, 2024, for the fiscal year 2025.
    HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "HEAL Initiative: Integrative Management of Chronic Pain and Opioid Use Disorder (OUD) for Whole Recovery: Health Systems." This initiative aims to develop strategies to enhance the sustainable and effective delivery of integrated care for individuals suffering from both chronic pain and OUD, addressing barriers at the health systems level. The importance of this opportunity lies in its focus on improving collaborative care models and implementation strategies to better manage these co-occurring conditions, which affect a significant portion of the population. Interested applicants, particularly small businesses with expertise in chronic pain management and OUD, are encouraged to prepare for the application process, with the estimated synopsis post date set for January 12, 2026, and the estimated award date anticipated for April 1, 2027. For further inquiries, potential applicants can contact Shelley Su, Ph.D., at IMPOWR@nih.gov or by phone at 301-402-3869.